Cargando…
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
Breast cancer (BC) is the most common malignancy in women worldwide and leads, in more than 70% of patients with advanced disease, to skeleton colonization and formation of bone metastases (BM). This condition implies a severe disability and deterioration of the quality of life, with consequent addi...
Autores principales: | D’Oronzo, Stella, Silvestris, Erica, Paradiso, Angelo, Cives, Mauro, Tucci, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215395/ https://www.ncbi.nlm.nih.gov/pubmed/32344743 http://dx.doi.org/10.3390/ijms21083022 |
Ejemplares similares
-
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
por: Mannavola, Francesco, et al.
Publicado: (2019) -
Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art
por: Gentile, Marica, et al.
Publicado: (2020) -
Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management
por: D'Oronzo, Stella, et al.
Publicado: (2018) -
The role of biomarkers in the management of bone-homing malignancies
por: D’Oronzo, Stella, et al.
Publicado: (2017) -
Osteotropism of neuroendocrine tumors: role of the CXCL12/CXCR4 pathway in promoting EMT in vitro
por: Cives, Mauro, et al.
Publicado: (2017)